Showing 35,644 results

New & experimental HIV treatments

After FDA hold, CytoDyn will appeal for pharma partnerships to save leronlimab

Editor's pick
FierceBiotech
31 March 2022

News from infohep, March 2022

March 2022
Vaccinations & immunisations

UK: Gay and bisexual men and those aged 15 and over to receive 2 doses of HPV vaccine

Editor's pick
UK Health Security Agency
31 March 2022
Finance & funding

Biden’s 2023 Budget Invests $9.8B in PrEP and Boosts Other HIV Funding

Editor's pick
POZ
31 March 2022
Improving HIV care

‘I’m Just Trying to Live’: Abuse and Punishment Pervade HIV Clinics

Editor's pick
TheBodyPro
31 March 2022
Access to healthcare

Global Fund called to account for stock shortages in Kenya, Mozambique

Editor's pick
Devex
31 March 2022
Injectable & long-acting HIV treatment

US: Cabenuva Approval Expanded to Include Adolescents With HIV

Editor's pick
Monthly Prescribing Reference
31 March 2022
Women

Ending HIV Criminalization Starts With Me

Editor's pick
POZ
31 March 2022
Access to healthcare

These Students Are Smuggling HIV Meds and Hormone Therapy Into Ukraine

Editor's pick
VICE
31 March 2022
Coronavirus

BHIVA Statement on JCVI recommendations for COVID vaccine Spring 2022 booster dose

Editor's pick
British HIV Association
31 March 2022
Injectable & long-acting PrEP

What is the use of anti-HIV injections when those who need it most can't use it?

Editor's pick
Bhekisisa
31 March 2022
Migrants, refugees & displaced people

Eastern EU countries in cry for help over refugee health costs

Editor's pick
POLITICO
31 March 2022
Support issues for children & young people

Training health-care workers in Indonesia to improve HIV services for young key populations

Editor's pick
UNAIDS
31 March 2022
Access to healthcare

Ukrainian Activist Discusses Russian Invasion's Devastating Impact on HIV Care and Harm Reduction in His Country

Editor's pick
TheBody
31 March 2022
HIV treatment for children & young people

ViiV Healthcare announces US FDA approval of Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV

Editor's pick
ViiV press release
31 March 2022
Liver disease

Fatty liver disease raises the risk of cardiovascular disease in people with HIV

News
30 March 2022
HIV in the arts & media

Journalists’ working conditions foster stigmatising coverage of HIV criminalisation

News
29 March 2022
Coronavirus

Early study suggests long-term antiretroviral therapy with protease inhibitors might prevent COVID-19 infection

Editor's pick
EurekAlert!
28 March 2022
Changing treatment

Outcomes of HIV Virologic Suppression After Switching to Dolutegravir/Lamivudine

Editor's pick
Infectious Disease Advisor
28 March 2022
Ageing & HIV

'Where I can be me': Inside Britain's first LGBT retirement home

Editor's pick
i news
28 March 2022
Access to healthcare

Public Health Catastrophe Looms in Ukraine, Experts Warn

Editor's pick
The New York Times
28 March 2022
Changing treatment

17 months average wait to switch from a failing HIV treatment regimen in African countries

News
28 March 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period

Editor's pick
ViiV press release
25 March 2022
Global health initiatives

Nkengasong’s PEPFAR Prospects and Hopes for Africa CDC 

Editor's pick
Health Policy Watch
25 March 2022